| Net sales | 414M |
| Cost of goods sold | 289M |
| Selling, general and administrative | 35M |
| Depreciation and amortization | |
| Research and development | |
| Facility closures, severance and related costs | 1M |
| Impairment charges | |
| Changes in estimates related to expected allowable claims | |
| Equity income | 0 |
| Operating profit (loss) | 51M |
| Interest expense | -8M |
| Loss on early extinguishment of debt | |
| Other expense, net | -1M |
| Reorganization items, net | |
| Earnings (loss) from continuing operations before income taxes | |
| Income tax benefit (provision) | -17M |
| Earnings (loss) from continuing operations | |
| Earnings (loss) from discontinued operations, net of tax | |
| Loss on sale of discontinued operations, net of tax | |
| Net earnings (loss) | 25M |
| Less: Net earnings attributed to non-controlling interests | |
| Net earnings (loss) attributable to Chemtura | |
| Earnings (loss) from continuing operations | |
| Earnings (loss) from discontinued operations, net of tax | |
| Loss on sale of discontinued operations, net of tax | |
| Net earnings (loss) attributable to Chemtura | |
| Weighted average shares outstanding - Basic | 63M |
| Weighted average shares outstanding - Diluted | 63.9M |
| Earnings (loss) from continuing operations | |
| Earnings (loss) from discontinued operations, net of tax | |
| Loss on sale of discontinued operations, net of tax | |
| Net earnings (loss) attributable to Chemtura | |